. . . . . . . . . . . "a(SCHEM:Aspirin) -| p(HGNC:CRP)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "High-dose aspirin treatment resulted in a approximately 25% reduction in fasting plasma glucose, associated with a approximately 15% reduction in total cholesterol and C-reactive protein, a approximately 50% reduction in triglycerides, and a approximately 30% reduction in insulin clearance, despite no change in body weight." . . "Selventa" . . . . "2014-07-03T14:30:03.169+02:00"^^ . . .